Comparative Preclinical Pharmacokinetics and Bioavailability of Antidepressant GSB-106 Tablet Form
- Авторы: Kolyvanov G.1, Zherdev V.1, Gribakina O.1, Bochkov P.1, Shevchenko R.1, Litvin A.1, Blynskaya E.2, Bueva V.2
-
Учреждения:
- Laboratory of Pharmacokinetics
- Laboratory of Finished Dosage Forms, V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
- Выпуск: Том 167, № 5 (2019)
- Страницы: 637-640
- Раздел: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/241978
- DOI: https://doi.org/10.1007/s10517-019-04587-w
- ID: 241978
Цитировать
Аннотация
Pharmacokinetics and relative bioavailability of antidepressant GSB-106 (hexamethylendiamide bis-(N-monosuccinyl-L-seryl-L-lysine) were determined in rabbits after single oral administration of the pharmaceutical substance and tablet mass. GSB-106 concentrations in the blood plasma were determined by HPLC-mass spectrometry. Relative bioavailability of GSB-106 tablet form was 160.79±24.33%.
Об авторах
G. Kolyvanov
Laboratory of Pharmacokinetics
Автор, ответственный за переписку.
Email: litbiopharm@yandex.ru
Россия, Moscow
V. Zherdev
Laboratory of Pharmacokinetics
Email: litbiopharm@yandex.ru
Россия, Moscow
O. Gribakina
Laboratory of Pharmacokinetics
Email: litbiopharm@yandex.ru
Россия, Moscow
P. Bochkov
Laboratory of Pharmacokinetics
Email: litbiopharm@yandex.ru
Россия, Moscow
R. Shevchenko
Laboratory of Pharmacokinetics
Email: litbiopharm@yandex.ru
Россия, Moscow
A. Litvin
Laboratory of Pharmacokinetics
Email: litbiopharm@yandex.ru
Россия, Moscow
E. Blynskaya
Laboratory of Finished Dosage Forms, V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
Email: litbiopharm@yandex.ru
Россия, Moscow
V. Bueva
Laboratory of Finished Dosage Forms, V. V. Zakusov Research Institute of Pharmacology, Russian Academy of Medical Sciences
Email: litbiopharm@yandex.ru
Россия, Moscow
![](/img/style/loading.gif)